Mary E. Matyskiela
Bristol-Myers Squibb (Germany)(DE)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis, Endoplasmic Reticulum Stress and Disease
Most-Cited Works
- → A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase(2016)641 cited
- → Complete subunit architecture of the proteasome regulatory particle(2012)617 cited
- → SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate(2018)333 cited
- → A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos(2017)287 cited
- → Conformational switching of the 26S proteasome enables substrate degradation(2013)267 cited
- → CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells(2020)213 cited
- → Molecular glue CELMoD compounds are regulators of cereblon conformation(2022)180 cited
- → An architectural map of the anaphase-promoting complex(2006)156 cited
- → Ubp6 deubiquitinase controls conformational dynamics and substrate degradation of the 26S proteasome(2015)135 cited
- → Analysis of Activator-Binding Sites on the APC/C Supports a Cooperative Substrate-Binding Mechanism(2009)103 cited